| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.3M | +19.4% |
| SG&A Expense | $9.0M | +210.6% |
| Operating Income | -$15.3M | -421.7% |
| Net Income | -$7.7M | -204.9% |
| EPS (Basic) | -$18.15 | +98.5% |
| EPS (Diluted) | -$18.15 | +98.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $3.7M | +88.5% |
| Total Assets | $6.2M | -27.5% |
| Current Liabilities | $7.4M | +43.1% |
| Total Liabilities | $8.1M | -43.4% |
| Stockholders' Equity | -$1.9M | +86.7% |